Peptides for PTSD & Trauma Recovery: Evidence vs Hype (2026)
An evidence-graded look at the three peptides marketed for PTSD and trauma — oxytocin, Selank and Semax — separating the mixed human oxytocin RCTs from anxiety-only and preclinical claims.
Semax
Semax is a recurring topic in our peptide coverage. This hub collects every article tagged Semax, newest first, each evidence-graded and tied to real, verifiable sources.
Best Peptides for Neuroprotection & Brain Health: Evidence (2026)
A clinical, evidence-graded ranking of the peptides marketed for neuroprotection — Cerebrolysin, Semax, ARA-290, SS-31/elamipretide and P021 — separating a modest, mixed human signal from elegant but preclinical-only mechanism.
Best Peptides for Memory & Cognitive Enhancement: Evidence (2026)
A clinical, evidence-graded ranking of the peptides marketed for memory — Cerebrolysin, Semax, Noopept, Dihexa and P021 — separating the disputed human RCT signal from preclinical mechanism, a retracted-data scandal, and pure marketing.
Best Peptides for Focus & Brain Fog: Clinical Evidence (2026)
A clinical, evidence-graded look at the peptides marketed for focus and "brain fog" — Semax, Selank, Cerebrolysin and the N-Acetyl modified analogs — separating the small human attention signal from preclinical mechanism and pure marketing.
Peptides for Depression & Mood: Evidence Review (2026)
A clinical, evidence-graded look at the three peptides marketed for depression — Cerebrolysin, Selank and Semax — separating secondary-endpoint human data and preclinical antidepressant signals from marketing hype.
Best Peptides for Anxiety & Stress: Clinical Evidence (2026)
A clinical, evidence-graded look at the four peptides marketed for anxiety and stress — Selank, N-Acetyl Selank Amidate, Semax and DSIP — separating the single human anxiety trial from preclinical and marketing claims.
Semax: Evidence, Mechanism, Dosing & Legal Status
A clinical monograph on Semax — the Russian-developed ACTH(4-10) heptapeptide used intranasally for stroke recovery and cognition. Real but single-country human data, graded B, with an unsettled 2026 FDA status.
N-Acetyl Semax Amidate: Evidence, Mechanism & Legal Status
A clinical monograph on N-Acetyl Semax Amidate — the terminally-stabilized analog of the Russian nootropic Semax. No human or animal data on the modified molecule, an unproven potency story, and an unsettled 2026 legal status.
Frequently asked
What is Semax?
Semax is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.
How often is the Semax hub updated?
This hub updates automatically whenever a new article is tagged Semax, so the latest coverage appears first.
Are Semax claims sourced?
Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.